HemoGenyx Company

New treatment for blood diseases, such as leukemia and lymphoma.
Technology: Cell therapy
Industry: Public
Headquarters: Buffalo, New York, United States
Founded Date: 2013-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: 61250000
Estimated Revenue: Less than $1M
Last Funding Date: 2020-11-18
Last Funding Type: Post-IPO Debt

Visit Website
hemogenyx@hemogenyx.com
http://twitter.com/hemogenyx
Register and Claim Ownership